✦ 24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Loading

Fetching the latest headlines…

NabkaNews aggregates headlines from thousands of publishers worldwide via Google News, and provides AI-generated summaries and briefings for convenience. Every story links to its original source. We do not host or claim ownership of third-party reporting, and AI summaries may contain errors — always verify with the original source.

24h Briefing Top Stories World U.S.India Business Technology Science Health Sports Entertainment

Disclaimer Privacy Policy Terms of Use

© 2026 NabkaNews · World · U.S. · India — updated continuously. NabkaNews is an independent news aggregator and is not affiliated with any publisher shown.

Avalyn Pharma Takes a Breath to Raise $300M in IPO Cash for Lung Drug Trials · NabkaNews

← Back to headlines

Avalyn Pharma Takes a Breath to Raise $300M in IPO Cash for Lung Drug Trials

MedCity News·Apr 30

This story is reported by MedCity News. Read what other outlets are saying below, then open the original report for full details.

Full coverage

Avalyn, in pursuit of better lung drugs, banks $300M in an IPO

BioPharma Dive·Apr 29

Chasing a tough-to-treat lung disease, Avalyn plans an IPO

BioPharma Dive·Apr 9

Oorja, run by Acceleron veterans, launches to make new fibrosis drugs

BioPharma Dive·May 20

View original report at MedCity News ↗